CAL101, an investigational therapy with the potential to treat pulmonary fibrosis, showed a favorable safety and pharmacological profile in a Phase 1 clinical trial, according to results announced by ...

The pulmonary toxicity of amiodarone and dronedarone was similar, both have pulmonary toxicity (n = 424, EBGM05 = 140.58 vs. n = 23, EBGM05 = 20.98) and pulmonary fibrosis (n = 258, EBGM05 = 38.73 vs.

Liver fibrosis is scarring of the liver. It has many causes, including alcohol-induced damage, infections, and diseases that harm the liver. Inflammation and injury of the liver can lead to scarring, ...

The term “progressive pulmonary fibrosis” or “PPF” is generally used to describe progressive lung fibrosis in an individual with an interstitial lung disease (ILD) other than idiopathic ...

Idiopathic pulmonary fibrosis (IPF) is characterized by a progressive decline in lung function, worsening quality of life, and high mortality. However, the rate and pattern of progression of IPF ...

Amiodarone therapy was commenced (200 mg 3 ... Cardiac MRI, repeated 2 weeks later, continued to show significant fibrosis (Figure 2). The short T1 inversion recovery signals were, however ...

The Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, China Idiopathic pulmonary fibrosis (IPF) ...